Vertex Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
VRTX Vertex Pharmaceuticals Inc
HBI HanesBrands Inc
TMKR Tastemaker Acquisition Corp
SPY SPDR® S&P 500 ETF Trust
STOR STORE Capital Corp
PIPP^ Pine Island Acquisition Corp
PEP PepsiCo Inc
$NASI5000LMN NASDAQ Asia Cnsmr Svcs Large Mid Cap
PNM PNM Resources Inc
CBLAQ CBL & Associates Properties Inc
Go

Health Care : Biotechnology | Large Cap Growth
Company profile

Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. The Company's marketed medicines are ORKAMBI and KALYDECO. ORKAMBI (lumacaftor in combination with ivacaftor) is approved as a treatment for patients having two copies (homozygous) of the Delta-F508 (F508del) mutation in their cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO (ivacaftor) is approved for the treatment of CF patients having the G551D mutation or other specified mutations in their CFTR gene. The Company's development programs in the field of CF include Tezacaftor (VX-661), VX-152, VX-440, VX-659, VX-445 and VX-371. VX-152, VX-440, VX-659 and VX-445 are CFTR corrector compounds.

Closing Price
$211.98
Day's Change
4.19 (2.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
212.60
Day's Low
206.39
Volume
(Light)
Volume:
1,704,848

10-day average volume:
2,342,889
1,704,848
  • Prev Close
    207.79
  • Today's Open
    208.23
  • Day's Range
    206.39-212.60
  • Avg Vol (10-day)
    2.3M
  • Last (time)
    4:00p ET 03/05/21
  • Last (size)
    1
  • 52-Wk Range
    197.47 - 306.08
    LowHigh
  • (03/18/20 - 07/07/20)
    7.35%
  • 47.0%
  • Market Cap
    55.1B
  • Shares Outstanding
    260.0M
  • 10.30
  • 20.57x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.7
  • 92.72
  • (% of float 02/15/21)
    1.54

Latest News

February 24, 2021
9:01 am ET
BusinessWire
February 03, 2021
8:45 am ET
PR Newswire
February 02, 2021
10:26 am ET
MarketWatch
February 01, 2021
4:01 pm ET
BusinessWire
2:30 pm ET
Accesswire
January 28, 2021
4:11 pm ET
BusinessWire
January 26, 2021
8:30 am ET
BusinessWire
January 22, 2021
9:01 am ET
BusinessWire
January 07, 2021
6:01 am ET
BusinessWire
December 28, 2020
5:04 am ET
BusinessWire
December 22, 2020
5:30 am ET
BusinessWire
December 21, 2020
11:30 am ET
BusinessWire
October 30, 2020
5:15 pm ET
MarketWatch
October 15, 2020
7:31 am ET
MarketWatch
6:36 am ET
MarketWatch
October 14, 2020
5:08 pm ET
MarketWatch
5:07 pm ET
MarketWatch
October 05, 2020
11:34 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.